Compare Globus Medical Inc. Class A Common Stock (GMED) vs US Global Jets ETF (JETS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs US Global Jets ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while US Global Jets ETF trades at $25.96 (market cap $766.85M). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 13.4× US Global Jets ETF's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and US Global Jets ETF for 27 Days on average.
| GMED | JETS | |
|---|---|---|
Market Cap | $10.25B | $766.85M |
Volume | 1,059,528 | 3,093,704 |
Sector | Health | Sector/Thematic |
52-Week High | $96.82 | $33.53 |
52-Week Low | $58.33 | $23.64 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
JETS (U.S. Global Jets ETF) trades at $26.80, down 0.81% amid bearish technical signals with 17 sell indicators versus 5 buy signals. The ETF faces headwinds from rising fuel costs and geopolitical tensions, though oversold RSI levels suggest potential near-term support. Recent news highlights competitive pressure from defense-focused aerospace ETFs that have outperformed JETS on total returns.
Outlook remains cautious given fuel price volatility and airline earnings uncertainty. Investment opportunity exists for contrarians betting on travel recovery, but risks include sustained high oil prices and weaker-than-expected demand. The ETF's focus on pure-play airlines increases sensitivity to operational cost pressures compared to diversified aerospace funds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →
